ArticleFrontiers in immunology2025

Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy.

Mithunah Krishnamoorthy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.